Copyright Reports & Markets. All rights reserved.

Global Pulmonary Drugs Market Data Survey Report 2013-2025

Buy now

Table of Contents

    1 Global Market Overview

    • 1.1 Scope of Statistics
      • 1.1.1 Scope of Products
      • 1.1.2 Scope of Manufacturers
      • 1.1.3 Scope of Application
      • 1.1.4 Scope of Type
      • 1.1.5 Scope of Regions/Countries
    • 1.2 Global Market Size

    2 Regional Market

    • 2.1 Regional Production
    • 2.2 Regional Demand
    • 2.3 Regional Trade

    3 Key Manufacturers

    • 3.1 AstraZeneca plc
      • 3.1.1 Company Information
      • 3.1.2 Product & Services
      • 3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.1.4 Recent Development
    • 3.2 Bayer AG
      • 3.2.1 Company Information
      • 3.2.2 Product & Services
      • 3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.2.4 Recent Development
    • 3.3 Teva Pharmaceutical Industries Ltd
      • 3.3.1 Company Information
      • 3.3.2 Product & Services
      • 3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.3.4 Recent Development
    • 3.4 Actelion Pharmaceuticals, Inc.
      • 3.4.1 Company Information
      • 3.4.2 Product & Services
      • 3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.4.4 Recent Development
    • 3.5 Boehringer Ingelheim GmbH
      • 3.5.1 Company Information
      • 3.5.2 Product & Services
      • 3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.5.4 Recent Development
    • 3.6 F. Hoffmann-La Roche Ltd.
      • 3.6.1 Company Information
      • 3.6.2 Product & Services
      • 3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.6.4 Recent Development
    • 3.7 Merck & Co., Inc.
      • 3.7.1 Company Information
      • 3.7.2 Product & Services
      • 3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.7.4 Recent Development
    • 3.8 Novartis AG
      • 3.8.1 Company Information
      • 3.8.2 Product & Services
      • 3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
      • 3.8.4 Recent Development
    • 3.9 GlaxoSmithKline plc
      • 3.9.1 Company Information
      • 3.9.2 Product & Services
      • 3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 3.10 Sunovion Pharmaceuticals
      • 3.10.1 Company Information
      • 3.10.2 Product & Services
      • 3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

    4 Major Application

    • 4.1 Asthma & COPD
      • 4.1.1 Overview
      • 4.1.2 Asthma & COPD Market Size and Forecast
    • 4.2 Allergic Rhinitis
      • 4.2.1 Overview
      • 4.2.2 Allergic Rhinitis Market Size and Forecast
    • 4.3 Pulmonary Arterial Hypertension
      • 4.3.1 Overview
      • 4.3.2 Pulmonary Arterial Hypertension Market Size and Forecast
    • 4.4 Cystic Fibrosis
      • 4.4.1 Overview
      • 4.4.2 Cystic Fibrosis Market Size and Forecast

    5 Market by Type

      5.By Inhaled Corticosteroids (ICS)

      • 5.1 Inhaled Corticosteroids (ICS)
        • 5.1.1 Overview
        • 5.1.2 Inhaled Corticosteroids (ICS) Market Size and Forecast
      • 5.2 Long-Acting Beta2-Agonists (LABA)
        • 5.2.1 Overview
        • 5.2.2 Long-Acting Beta2-Agonists (LABA) Market Size and Forecast
      • 5.3 Antihistamine
        • 5.3.1 Overview
        • 5.3.2 Antihistamine Market Size and Forecast
      • 5.4 Vasodilators
        • 5.4.1 Overview
        • 5.4.2 Vasodilators Market Size and Forecast
      • 5.5 Short-Acting Beta2-Agonists (SABA)
        • 5.5.1 Overview
        • 5.5.2 Short-Acting Beta2-Agonists (SABA) Market Size and Forecast
      • 5.6 Anticholinergics
        • 5.6.1 Overview
        • 5.6.2 Anticholinergics Market Size and Forecast
      • 5.7 Combination Drugs
        • 5.7.1 Overview
        • 5.7.2 Combination Drugs Market Size and Forecast
      • 5.8 MAbs
        • 5.8.1 Overview
        • 5.8.2 MAbs Market Size and Forecast
      • 5.9 Enzymes
        • 5.9.1 Overview
        • 5.9.2 Enzymes Market Size and Forecast
      • 5.10 Antibiotics & Antileukotrienes
        • 5.10.1 Overview
        • 5.10.2 Antibiotics & Antileukotrienes Market Size and Forecast

      6 Price Overview

      • 6.1 Price by Manufacturers
      • 6.2 Price by Application
      • 6.3 Price by Type

      7 Conclusion

      Summary
      The global Pulmonary Drugs market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including:
      Global market size and forecast
      Regional market size, production data and export & import
      Key manufacturers profile, products & services, sales data of business
      Global market size by Major Application
      Global market size by Major Type
      Key manufacturers are included based on company profile, sales data and product specifications etc.:
      AstraZeneca plc
      Bayer AG
      Teva Pharmaceutical Industries Ltd
      Actelion Pharmaceuticals, Inc.
      Boehringer Ingelheim GmbH
      F. Hoffmann-La Roche Ltd.
      Merck & Co., Inc.
      Novartis AG
      GlaxoSmithKline plc
      Sunovion Pharmaceuticals
      Major applications as follows:
      Asthma & COPD
      Allergic Rhinitis
      Pulmonary Arterial Hypertension
      Cystic Fibrosis
      Major Type as follows:
      Inhaled Corticosteroids (ICS)
      Long-Acting Beta2-Agonists (LABA)
      Antihistamine
      Vasodilators
      Short-Acting Beta2-Agonists (SABA)
      Anticholinergics
      Combination Drugs
      MAbs
      Enzymes
      Antibiotics & Antileukotrienes
      Regional market size, production data and export & import:
      Asia-Pacific
      North America
      Europe
      South America
      Middle East & Africa

      Buy now